X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (363) 363
Book Review (34) 34
Book Chapter (18) 18
Publication (18) 18
Book / eBook (14) 14
Web Resource (8) 8
Conference Proceeding (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (202) 202
humans (184) 184
clinical trials (106) 106
abridged index medicus (93) 93
cardiac & cardiovascular systems (72) 72
female (71) 71
male (61) 61
united states (54) 54
middle aged (47) 47
mortality (41) 41
research design (39) 39
statistics (37) 37
statistics & probability (37) 37
aged (36) 36
medicine, general & internal (35) 35
adult (34) 34
medicine, research & experimental (33) 33
double-blind method (32) 32
clinical trials as topic (31) 31
heart failure (31) 31
clinical-trials (30) 30
peripheral vascular disease (29) 29
research (28) 28
treatment outcome (27) 27
drug therapy (26) 26
risk (26) 26
risk factors (26) 26
american heart association (25) 25
data interpretation, statistical (24) 24
pharmacology & pharmacy (24) 24
aha scientific statements (23) 23
care and treatment (23) 23
methods (22) 22
clinical trials as topic - methods (21) 21
design (21) 21
risk assessment (21) 21
medical research (20) 20
time factors (20) 20
cardiovascular (19) 19
cardiovascular diseases (19) 19
public, environmental & occupational health (19) 19
medical informatics (18) 18
therapy (18) 18
cardiovascular disease (17) 17
randomized controlled trials as topic (17) 17
analysis (16) 16
clinical trials data monitoring committees (16) 16
usage (16) 16
cardiology - standards (15) 15
follow-up studies (15) 15
heart failure - drug therapy (15) 15
internal medicine (15) 15
practice guidelines (15) 15
prevention (14) 14
statistics for life sciences, medicine, health sciences (14) 14
survival (14) 14
age factors (13) 13
clinical trial (13) 13
diabetic retinopathy (13) 13
epidemiology (13) 13
monitoring (13) 13
morbidity (13) 13
myocardial infarction (13) 13
patients (13) 13
safety (13) 13
survival analysis (13) 13
acute myocardial-infarction (12) 12
bias (12) 12
biomarkers (12) 12
biometry (12) 12
cardiology and cardiovascular medicine (12) 12
heart attacks (12) 12
heart-failure (12) 12
mathematical & computational biology (12) 12
myocardial-infarction (12) 12
percutaneous coronary intervention (12) 12
prognosis (12) 12
adrenergic beta-antagonists - therapeutic use (11) 11
chronic disease (11) 11
data processing (11) 11
heart failure - mortality (11) 11
models, statistical (11) 11
oncology (11) 11
prospective studies (11) 11
article (10) 10
blood pressure (10) 10
cardiac patients (10) 10
clinical trials as topic - standards (10) 10
committees (10) 10
diabetic retinopathy - epidemiology (10) 10
diagnosis (10) 10
ethics (10) 10
evaluation (10) 10
heart (10) 10
hospitalization (10) 10
probability (10) 10
public health (10) 10
studies (10) 10
trials (10) 10
wisconsin (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, 4th ed., ISBN 1441915850, xviii, 445
Clinical trials are an essential step in improving health care. The fourth edition of this standard reference updates areas in which progress has been made,... 
Clinical trials | Research Design | Clinical Trials as Topic | Cancer Research | Oncology | Public Health/Gesundheitswesen | Statistics for Life Sciences, Medicine, Health Sciences | Statistics | Epidemiology
Book
by Gatsonis, Constantine A and Aberle, Denise R and Berg, Christine D and Black, William C and Church, Timothy R and Fagerstrom, Richard M and Galen, Barbara and Gareen, Ilana F and Goldin, Jonathan and Gohagan, John K and Hillman, Bruce and Jaffe, Carl and Kramer, Barnett S and Lynch, David and Marcus, Pamela M and Schnall, Mitchell and Sullivan, Daniel C and Sullivan, Dorothy and Zylak, Carl J and Cagnon, Christopher and Cody, Dianna and Fletcher, Glenn and Flynn, Michael J and Judy, Philip F and Kruger, Randell and Larke, Frederick J and McNitt-Gray, Michael and Payne, Thomas and Anthony Seibert, J and Wu, Xizeng and Abbott, Gerald and Amorosa, Judith K and Barr, Richard G and Boiselle, Phillip M and Chiles, Caroline and Clark, Robert and Coppage, Lynn and Falk, Robert and Fishman, Elliot K and Gemmel, David and Goldin, Jonathan G and Goodman, Eric and Hart, Eric M and Hazelton, Todd and Johnson, Elizabeth and Kazerooni, Ella and McComb, Barbara and McLennan, Geoffrey and Munden, Reginald F and Ravenel, James and Sullivan, Michael and Swensen, Stephen J and Torigian, Drew A and Vydareny, Kay H and Worrell, John A and Balkin, Peter and Fouad, Mona and Freedman, Matthew T and Garg, Kavita and Gelmann, Edward P and Gierada, David S and Hocking, William and Inampudi, Subbarao and Isaacs, Claudine and Kvale, Paul and Mann, Howard and Manor, William and Nath, Hrudaya and Reding, Douglas and Spizarny, David L and Strollo, Diane C and Waltz, John and Chen, Mei-Hsiu and Duan, Fenghai and Izmirilian, Grant and Pinsky, Paul and Prorok, Philip C and Miller, Anthony B and Edelman, Martin J and Evans, William K and Fontana, Robert S and Machtay, Mitchell and Clark, Kenneth W and Clingan, Kathy L and Ford, Melissa B and Márquez, Guillermo and Moore, Steven M and Ohan, Peter and Payne, Thomas J and Peace, Steven and Rosenbaum, Jennifer L and Barr, Richard and Black, William and Torigian, Drew and Vydareny, Kay and Worrell, John and Young, Robert C and Alberts, David and DeMets, David and Greenwald, Peter and ... and Natl Lung Screening Trial Res Team and National Lung Screening Trial Research Team
Radiology, ISSN 0033-8419, 01/2011, Volume 258, Issue 1, pp. 243 - 253
Journal Article
by Hernandez, Adrian F and Green, Fiona and Green, Jennifer B and Janmohamed, Salim and D'Agostino, Ralph B and Granger, Christopher B and Jones, Michael and Jones, Nigel P and Leiter, Lawrence A and Rosenberg, Anne E and Rosenberg, Anne and Sigmon, Kristina and Sigmon, Kristina N and Somerville, Matthew and Somerville, Matthew C and Thorpe, Karl and Thorpe, Karl M and McMurray, John J V and McMurray, John J.V and Del Prato, Stefano and Califf, Robert M and Holman, Rury and DeMets, David and Riddle, Matthew and Goodman, Shaun and McGuire, Darren and Alexander, Karen and Devore, Adam and Melloni, Chiara and Patel, Chetan and Patel, Rajesh and Patel, Vickas and Patel, Prashant and Patel, Rajivkumar and Kong, David and Bloomfield, Gerald and Roe, Matthew and Tricoci, Pierluigi and Harrison, Rob and Harrison, Lindsay and Lopes, Renato and Mathews, Robin and Mehta, Anand and Mehta, Rajendra and Schuyler Jones, William and Vemulapalli, Sreekanth and Povsic, Thomas and Eapen, Zubin and Dombrowski, Keith and Kolls, Brad and Jordan, Dedrick and Ambrosy, Andrew and Greene, Deb and Greene, Stephen and Mandawat, Aditya and Shavadia, Jay and Cooper, John and Cooper, Lauren and Sharma, Abhinav and Sharma, Richa and Guimaraes, Patricia and Friedman, Daniel and Wilson, Matt and Wilson, Tim and Endsley, Patricia and Gentry, Tracy and Collier, Jeannie and Perez, Kathleen and James, Kourtnei and James, Rachel and Roush, Jennifer and Pope, Connie and Howell, Christina and Johnson, Megan and Johnson, David and Johnson, Andrew and Bailey, Matt and Cole, Joanna and Akers, Teresa and Vandyne, Beth and Thomas, Betsy and Rich, Jenny and Bartone, Susan and Beaulieu, Gail and Brown, Judith and Brown, Kim and Chau, Tuan and Christian, Tamra and Coker, Rebecca and Haddock, Trevorlyn and Jenkins, Wendy and Haque, Ghazala and Marquess, Marsha and Pesarchick, Jean and Rethaford, Renee and Stone, Allegra and Al Kawas, Firas and Anderson, Michelle and Enns, Robert and Sinay, Isaac and ... and Harmony Outcomes Comm Investigator and Harmony Outcomes committees and investigators
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 09/2014, Volume 312, Issue 10, pp. 1006 - 1015
Journal Article